Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1247761.RA0EcJZW56xzy6_CeSSGYL6lyr2yUWpHtven06bAt6L0Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1247761.RA0EcJZW56xzy6_CeSSGYL6lyr2yUWpHtven06bAt6L0Y130_assertion type Assertion NP1247761.RA0EcJZW56xzy6_CeSSGYL6lyr2yUWpHtven06bAt6L0Y130_head.
- NP1247761.RA0EcJZW56xzy6_CeSSGYL6lyr2yUWpHtven06bAt6L0Y130_assertion description "[In this study, we found that hepatocyte growth factor (HGF), ligand of MET, mediated the resistance to alectinib, but not to crizotinib, via the MET signal in ALK-positive NSCLC cell lines (H3122 and H2228 cell lines).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247761.RA0EcJZW56xzy6_CeSSGYL6lyr2yUWpHtven06bAt6L0Y130_provenance.
- NP1247761.RA0EcJZW56xzy6_CeSSGYL6lyr2yUWpHtven06bAt6L0Y130_assertion evidence source_evidence_literature NP1247761.RA0EcJZW56xzy6_CeSSGYL6lyr2yUWpHtven06bAt6L0Y130_provenance.
- NP1247761.RA0EcJZW56xzy6_CeSSGYL6lyr2yUWpHtven06bAt6L0Y130_assertion SIO_000772 25502629 NP1247761.RA0EcJZW56xzy6_CeSSGYL6lyr2yUWpHtven06bAt6L0Y130_provenance.
- NP1247761.RA0EcJZW56xzy6_CeSSGYL6lyr2yUWpHtven06bAt6L0Y130_assertion wasDerivedFrom befree-2016 NP1247761.RA0EcJZW56xzy6_CeSSGYL6lyr2yUWpHtven06bAt6L0Y130_provenance.
- NP1247761.RA0EcJZW56xzy6_CeSSGYL6lyr2yUWpHtven06bAt6L0Y130_assertion wasGeneratedBy ECO_0000203 NP1247761.RA0EcJZW56xzy6_CeSSGYL6lyr2yUWpHtven06bAt6L0Y130_provenance.